CONTACT OUR SALES

Automation Solution – UNITYdx

Essential Automation Solution Components Technology

  • Digital Monitoring of Safety Communications with site
  • Tracking of Delivery Receipts and Acknowledgement Compliance
  • Custom Configurations for Site Reminders and Email templates
  • Complete Logical Separation of Sponsor (Customer) data
  • Secure login using Multi-Factor Authentication
  • Pre-Validated as per GAMP-5 guidelines
  • Permission-based Access Control for Software Features, Read-only access
  • 21CFR Part11 compliant Audit Trail Maintenance

 

Solution Drivers

  1. High Volume Communication that requires Tracking
  2. Highly Available Infrastructure – Secure, with Backup and Redundant Servers
  3. Secure Communication, Complete Audit Trail and Tracking
  4. Configurable, Regulatory Compliant

 

Service

  • Simplified sync with Safety Systems via E2B R3 XML upload, EDI connection
  • Automated assessment of Regulatory, Site and EC/IRB reporting timelines via Reporting Rules
  • Detailed Compliance Reports with case-level and site-level as well as aggregated data presentation
  • Custom Templates for Site Notifications and Reminders
  • Cross-Reporting for multi-country trials
  • Retrospective Reporting for New Sites joining a study
  • Trial, Contact, Site and Product Masters for rapid integration with Safety and Clinical Databases

 

Benefits of Automation in Safety Document Distribution

    Safety Document* Distribution Solution for Clinical Sites (* 7/15-day SUSARs,

DSURs, USRs)

 

  1. Safety Document Distribution with Digital Tracking:
    • ENHANCED COMPLIANCE TRACKING
      User-friendly dashboard with study/ site/ product-specific filters for data and reports
  2. Secure Transmission of Reports
    • SECURE TRANSMISSION
      21 CFR Part11 compliant, Sign-in via secure access code received on verified email
  3. Reduce Human Effort and Probability of Error
    • GREATER PROCESS EFFICIENCY
      Automatic tracking and reminders, Cross-reporting, Retrospective reporting. Can be integrated with a CTMS for real-time updates

 

About UNITYTMdx

Soterius offers its in-house tool SUSAR Notification, UNITYTMdx, which automates the sending and tracking of SUSARs to the Clinical Trial Sites. System integration and standardization allow UNITYTMdx to work with any standard safety database. Multi-channel communication hub ensures prompt, compliant, efficient, and secure communication between Clinical Trial sites, Safety Teams (CROs and Sponsors), and Clinical teams.

 

Challenges in Manual process of SUSAR Notifications

  • Lack of regulatory compliant audit trails
  • Excel-based tracking prone to data integrity issues
  • Super busy Sites and Investigators do not respond
  • Maintenance of contact information on Excel prone to error
  • Multiple emails for1 SUSAR in case of multiple studies at a Site.
  • Institutional policies block email delivery notifications

 

Implementation Strategies

Transition, Integrations and Training

Key Takeaways

  1. Regulatory Compliance: Prompt SUSAR communication; Inspection Findings
  2. Manual Process of SUSAR Reporting is prone to errors, inadequate documentation and lack of audit trails
  3. Automation enhances process efficiency, mitigates risks in ensuring compliance and saves time and effort
  4. Ensuring data security with robust measures to protect sensitive information related to SUSAR notifications
  5. Successful Implementation needs a partner with Safety, Validation and Quality Assurance Expertise
  6. Aim is to have a Robust, Efficient and Compliant Solution for SUSAR / Safety Document Communication

About Soterius

Soterius is a strong team of pharma professionals who design customized, innovative, and cost-efficient processes for clinical safety, pharmacovigilance, and medical affairs. Our deep industry knowledge and up to date insights let us combine agile, people powered intelligence in pioneering customer centric solutions. Our innovative technology solutions include engagement tools and communications platforms to create a unified and compliant medical access facility. With a strong global presence, we provide comprehensive clinical and post marketed safety services, that include aggregate report writing, signal detection and management, global literature surveillance, risk management, case processing and regulatory reporting. We use state-of-the-art technologies to solve complex safety operations problems, be it case processing, intake, site reporting for clinical trials, or literature search and management. We have one of the most accurate solutions for case intake and case processing using AI.

We support companies from the initial development stage of a drug/vaccine to the approval and ultimate marketing of the therapy, supporting ongoing operations and regulatory commitments globally.

Authors

Tanvi Chaturvedi

Tanvi Chaturvedi

Associate Director, PV Operations & Technology

Tanvi is a pharmacist with over 12+ years of experience. She has expertise in pre-
approval and post-marketing safety and has managed end-to-end project setup for
clients including process development, database setup with data migration and
validation, transition of PV and MI services and team onboarding. She has
experience across various PV domains like case processing, literature management,
regulatory intelligence and pharmacovigilance quality assurance. She is eligible to
provide Responsible Person for EudraVigilance (RPEV) services to Sponsors of
Clinical Trials in the EEA.

Disclaimer

Copyright 2025 by Soterius, Inc. All rights reserved. Soterius logo are trademarks or registered trademarks of Soterius in all jurisdictions. Other marks may be trademarks or registered trademarks of their respective owners. The information you see, hear or read on the pages within this presentation, as well as the presentation’s form and substance, are subject to copyright protection. In no event, may you use, distribute, copy, reproduce, modify, distort, or transmit the information or any of its elements, such as text, images or concepts, without the prior written permission of Soterius. No license or right pertaining to any of these trademarks shall be granted without the written permission of Soterius (and any of its global offices and/or affiliates). Soterius reserves the right to legally enforce any infringement of its intellectual property, copyright and trademark rights. Any content presented herewith should only be considered for general informational purposes and should not be considered as specific to the requirements of any particular organisation or for any specific purpose. Soterius does not make any representations or warranties about the completeness, reliability, appropriateness, relevance, or accuracy of the content presented here.